<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Arnold EM</submitter><funding>NCATS NIH HHS</funding><funding>NICHD NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NIMH NIH HHS</funding><funding>National Institute of Child Health and Human Development</funding><pagination>215-221</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10922292</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>95(3)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Youth living with HIV (YLH) have an increased risk for psychosocial stressors that can affect their antiretroviral (ARV) adherence. We examined factors associated with self-reported ARV adherence among YLH ages 12-24 years old.&lt;h4>Setting&lt;/h4>YLH (N = 147) were recruited in Los Angeles, CA, and New Orleans, LA from 2017 to 2020.&lt;h4>Methods&lt;/h4>YLH whose self-reported recent (30 days) ARV adherence was "excellent" or "very good" were compared with nonadherent YLH on sociodemographic, clinical, and psychosocial factors using univariate and multivariate analyses.&lt;h4>Results&lt;/h4>Participants were predominantly male (88%), and 81% identified as gay, bisexual, transgender, queer, or other. The mean duration on ARV was 27 months (range 0-237 months). Most YLH (71.2%) self-reported being adherent, and 79% of those who self-reported adherence were also virally suppressed (&lt;200 copies/mL). Multivariate analysis indicated being adherent was significantly associated with white race [aOR = 8.07, confidence intervals (CI): 1.45 to 74.0], Hispanic/Latinx ethnicity [aOR = 3.57, CI: 1.16 to 12.80], more social support [aOR = 1.11, CI: 1.05 to 1.18], and being on ARV for a shorter duration [aOR = 0.99, CI: 0.97 to 0.99]. Mental health symptoms, substance use, age, and history of homelessness or incarceration were unrelated to adherence.&lt;h4>Conclusions&lt;/h4>Enhancing efforts to provide support for adherence to non-white youth, and those with limited social support and who have been on ARV treatment longer, may help increase viral suppression among YLH.</pubmed_abstract><journal>Journal of acquired immune deficiency syndromes (1999)</journal><pubmed_title>Factors Associated With Antiretroviral Adherence Among Youth Living With HIV.</pubmed_title><pmcid>PMC10922292</pmcid><funding_grant_id>U19HD089886</funding_grant_id><funding_grant_id>P30 AI028697</funding_grant_id><funding_grant_id>UL1 TR000124</funding_grant_id><funding_grant_id>UL1 TR001881</funding_grant_id><funding_grant_id>U19 HD089886</funding_grant_id><funding_grant_id>P30 MH058107</funding_grant_id><pubmed_authors>Swendeman D</pubmed_authors><pubmed_authors>Kamal S</pubmed_authors><pubmed_authors>Rotheram-Borus MJ</pubmed_authors><pubmed_authors>Gertsch W</pubmed_authors><pubmed_authors>Arnold EM</pubmed_authors><pubmed_authors>Bridges SK</pubmed_authors><pubmed_authors>Norwood P</pubmed_authors><pubmed_authors>Adolescent Medicine Trials Network (ATN) CARES Team</pubmed_authors></additional><is_claimable>false</is_claimable><name>Factors Associated With Antiretroviral Adherence Among Youth Living With HIV.</name><description>&lt;h4>Background&lt;/h4>Youth living with HIV (YLH) have an increased risk for psychosocial stressors that can affect their antiretroviral (ARV) adherence. We examined factors associated with self-reported ARV adherence among YLH ages 12-24 years old.&lt;h4>Setting&lt;/h4>YLH (N = 147) were recruited in Los Angeles, CA, and New Orleans, LA from 2017 to 2020.&lt;h4>Methods&lt;/h4>YLH whose self-reported recent (30 days) ARV adherence was "excellent" or "very good" were compared with nonadherent YLH on sociodemographic, clinical, and psychosocial factors using univariate and multivariate analyses.&lt;h4>Results&lt;/h4>Participants were predominantly male (88%), and 81% identified as gay, bisexual, transgender, queer, or other. The mean duration on ARV was 27 months (range 0-237 months). Most YLH (71.2%) self-reported being adherent, and 79% of those who self-reported adherence were also virally suppressed (&lt;200 copies/mL). Multivariate analysis indicated being adherent was significantly associated with white race [aOR = 8.07, confidence intervals (CI): 1.45 to 74.0], Hispanic/Latinx ethnicity [aOR = 3.57, CI: 1.16 to 12.80], more social support [aOR = 1.11, CI: 1.05 to 1.18], and being on ARV for a shorter duration [aOR = 0.99, CI: 0.97 to 0.99]. Mental health symptoms, substance use, age, and history of homelessness or incarceration were unrelated to adherence.&lt;h4>Conclusions&lt;/h4>Enhancing efforts to provide support for adherence to non-white youth, and those with limited social support and who have been on ARV treatment longer, may help increase viral suppression among YLH.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2026-06-01T08:52:13.491Z</modification><creation>2025-04-07T11:28:36.84Z</creation></dates><accession>S-EPMC10922292</accession><cross_references><pubmed>37977178</pubmed><doi>10.1097/qai.0000000000003345</doi><doi>10.1097/QAI.0000000000003345</doi></cross_references></HashMap>